1-20 of 46
Anne L Peters
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Overnight Glucose on Next-Day Functioning in Adults With Type 1 Diabetes: An Exploratory Intensive Longitudinal Study

Elizabeth A. Pyatak, Donna Spruijt-Metz, Stefan Schneider, Raymond Hernandez, Loree T. Pham, Claire J. Hoogendoorn, Anne L. Peters, Jill Crandall, Haomiao Jin, Pey-Jiuan Lee, Jeffrey S. Gonzalez
Journal: Diabetes Care
Diabetes Care 2023;46(7):1345–1353
https://doi.org/10.2337/dc22-2008
Published: 02 March 2023
View article titled, Impact of Overnight Glucose on Next-Day Functioning in Adults With Type 1 Diabetes: An Exploratory Intensive Longitudinal Study
Open the PDF for Impact of Overnight Glucose on Next-Day Functioning in Adults With Type 1 Diabetes: An Exploratory Intensive Longitudinal Study in another window
Journal Articles

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy

Georgia M. Davis, Anne L. Peters, Bruce W. Bode, Anders L. Carlson, Bonnie Dumais, Todd E. Vienneau, Lauren M. Huyett, Trang T. Ly
Journal: Diabetes Care
Diabetes Care 2023;46(4):742–750
https://doi.org/10.2337/dc22-1915
Published: 14 February 2023
View article titled, Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
Open the PDF for Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy in another window
Journal Articles

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Jennifer L. Sherr, Lutz Heinemann, G. Alexander Fleming, Richard M. Bergenstal, Daniela Bruttomesso, Hélène Hanaire, Reinhard W. Holl, John R. Petrie, Anne L. Peters, Mark Evans
Journal: Diabetes Care
Diabetes Care 2022;45(12):3058–3074
https://doi.org/10.2337/dci22-0018
Published: 06 October 2022
View article titled, Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association
Open the PDF for Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association in another window
Journal Articles

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Richard I.G. Holt, J. Hans DeVries, Amy Hess-Fischl, Irl B. Hirsch, M. Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy Pettus, Eric Renard, Jay S. Skyler, Frank J. Snoek, Ruth S. Weinstock, Anne L. Peters
Journal: Diabetes Care
Diabetes Care 2021;44(11):2589–2625
https://doi.org/10.2337/dci21-0043
Published: 18 October 2021
View article titled, The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Open the PDF for The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) in another window
Journal Articles

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin

Grazia Aleppo, Roy W. Beck, Ryan Bailey, Katrina J. Ruedy, Peter Calhoun, Anne L. Peters, Rodica Pop-Busui, Athena Philis-Tsimikas, Shichun Bao, Guillermo Umpierrez, Georgia Davis, Davida Kruger, Anuj Bhargava, Laura Young, John B. Buse, Janet B. McGill, Thomas Martens, Quang T. Nguyen, Ian Orozco, William Biggs, K. Jean Lucas, William H. Polonsky, David Price, Richard M. Bergenstal, MOBILE Study Group, Thomas Martens, Anders Carlson, Richard M. Bergenstal, Sharon Chambers, Shoua Yang, Laura Young, John Buse, M. Sue Kirkman, Alexander Kass, Rachael Fraser, Davida Kruger, Terra Cushman, Georgia Davis, Clementina Ramos, Guillermo Umpierrez, Anne L. Peters, Maria Magar, Martha Walker, Sara Serafin-Dokhan, Janet B. McGill, Maamoun Salam, Stacy Hurst, Mary Jane Clifton, Grazia Aleppo, Jelena Kravarusic, Anupam Bansal, Candice Fulkerson, Rodica Pop-Busui, Lynn Ang, Caroline Richardson, Kara Mizokami-Stout, Jake Reiss, Virginia Leone, Anuj Bhargava, Kirstie Stifel, Athena Philis-Tsimikas, George Dailey, Amy Change, James McCallum, Maria Isabel Garcia, Shichun Bao, Dianne Davis, Cynthia Lovell, Connie Root, William Biggs, Freida Toler, Lori Wilhelm, Robin Eifert, Lorena Murguia, Becky Cota, Quang T. Nguyen, Loida Nguyen, Randie Lipski, Ian Orozco, Mary Katherine Lawrence, Adelle Fournier, Matthew Carter, K. Jean Lucas, Stephanie Hoover, Roy W. Beck, Katrina J. Ruedy, Peter Calhoun, Ryan Bailey, Nathan Cohen, Thomas Mouse, Jessica Rusnak, Tiffany Campos, David Price, Nelly Njeru, Tom Arant, Stayce E. Beck, Andrew Balo
Journal: Diabetes Care
Diabetes Care 2021;44(12):2729–2737
https://doi.org/10.2337/dc21-1304
Published: 29 September 2021
View article titled, The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Open the PDF for The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin in another window
Journal Articles

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies

Anne L. Peters, Darren K. McGuire, Thomas Danne, Jake A. Kushner, Helena W. Rodbard, Ketan Dhatariya, Sangeeta Sawhney, Phillip Banks, Wenjun Jiang, Michael J. Davies, Pablo Lapuerta
Journal: Diabetes Care
Diabetes Care 2020;43(11):2713–2720
https://doi.org/10.2337/dc20-0924
Published: 14 September 2020
View article titled, Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies
Open the PDF for Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies in another window
Journal Articles

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

G. Alexander Fleming, John R. Petrie, Richard M. Bergenstal, Reinhard W. Holl, Anne L. Peters, Lutz Heinemann
Journal: Diabetes Care
Diabetes Care 2020;43(1):250–260
https://doi.org/10.2337/dci19-0062
Published: 12 December 2019
View article titled, Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Open the PDF for Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group in another window
Journal Articles

The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey

Rebecca Myerson, John Romley, Tommy Chiou, Anne L. Peters, Dana Goldman
Journal: Diabetes Care
Diabetes Care 2019;42(11):e179–e180
https://doi.org/10.2337/dc19-0081
Published: 23 September 2019
View article titled, The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey
Open the PDF for The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey in another window
Journal Articles

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

Thomas Danne, Bertrand Cariou, John B. Buse, Satish K. Garg, Julio Rosenstock, Phillip Banks, Jake A. Kushner, Darren K. McGuire, Anne L. Peters, Sangeeta Sawhney, Paul Strumph
Journal: Diabetes Care
Diabetes Care 2019;42(5):919–930
https://doi.org/10.2337/dc18-2149
Published: 04 March 2019
View article titled, Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program
Open the PDF for Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program in another window
Includes: Supplementary data
Journal Articles

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

Thomas Danne, Satish Garg, Anne L. Peters, John B. Buse, Chantal Mathieu, Jeremy H. Pettus, Charles M. Alexander, Tadej Battelino, F. Javier Ampudia-Blasco, Bruce W. Bode, Bertrand Cariou, Kelly L. Close, Paresh Dandona, Sanjoy Dutta, Ele Ferrannini, Spiros Fourlanos, George Grunberger, Simon R. Heller, Robert R. Henry, Martin J. Kurian, Jake A. Kushner, Tal Oron, Christopher G. Parkin, Thomas R. Pieber, Helena W. Rodbard, Desmond Schatz, Jay S. Skyler, William V. Tamborlane, Koutaro Yokote, Moshe Phillip
Journal: Diabetes Care
Diabetes Care 2019;42(6):1147–1154
https://doi.org/10.2337/dc18-2316
Published: 06 February 2019
View article titled, International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
Open the PDF for International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors in another window
Includes: Supplementary data
Journal Articles

T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes

Lawrence Fisher, Danielle Hessler, William H. Polonsky, Umesh Masharani, Susan Guzman, Vicky Bowyer, Lisa Strycker, Andrew Ahmann, Marina Basina, Ian Blumer, Charles Chloe, Sarah Kim, Anne L. Peters, Martha Shumway, Karen Weihs, Patricia Wu
Journal: Diabetes Care
Diabetes Care 2018;41(9):1862–1869
https://doi.org/10.2337/dc18-0391
Published: 05 July 2018
View article titled, T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes
Open the PDF for T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes in another window
Journal Articles

HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study

Thomas Danne, Bertrand Cariou, Phillip Banks, Michael Brandle, Helmut Brath, Edward Franek, Jake A. Kushner, Pablo Lapuerta, Darren K. McGuire, Anne L. Peters, Sangeeta Sawhney, Paul Strumph
Journal: Diabetes Care
Diabetes Care 2018;41(9):1981–1990
https://doi.org/10.2337/dc18-0342
Published: 24 June 2018
View article titled, HbA<sub>1c</sub> and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study
Open the PDF for HbA<sub>1c</sub> and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study in another window
Includes: Supplementary data
Journal Articles

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

John B. Buse, Satish K. Garg, Julio Rosenstock, Timothy S. Bailey, Phillip Banks, Bruce W. Bode, Thomas Danne, Jake A. Kushner, Wendy S. Lane, Pablo Lapuerta, Darren K. McGuire, Anne L. Peters, John Reed, Sangeeta Sawhney, Paul Strumph
Journal: Diabetes Care
Diabetes Care 2018;41(9):1970–1980
https://doi.org/10.2337/dc18-0343
Published: 24 June 2018
View article titled, Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
Open the PDF for Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study in another window
Includes: Supplementary data
Journal Articles

Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study

Edward W. Gregg, Ji Lin, Barbara Bardenheier, Haiying Chen, W. Jack Rejeski, Xiaohui Zhuo, Andrea L. Hergenroeder, Stephen B. Kritchevsky, Anne L. Peters, Lynne E. Wagenknecht, Edward H. Ip, Mark A. Espeland, for the Look AHEAD Study Group
Journal: Diabetes Care
Diabetes Care 2018;41(5):1040–1048
https://doi.org/10.2337/dc17-2110
Published: 15 March 2018
View article titled, Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study
Open the PDF for Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study in another window
Includes: Supplementary data
Journal Articles

Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial

Elizabeth A. Pyatak, Kristine Carandang, Cheryl L.P. Vigen, Jeanine Blanchard, Jesus Diaz, Alyssa Concha-Chavez, Paola A. Sequeira, Jamie R. Wood, Robin Whittemore, Donna Spruijt-Metz, Anne L. Peters
Journal: Diabetes Care
Diabetes Care 2018;41(4):696–704
https://doi.org/10.2337/dc17-1634
Published: 19 January 2018
View article titled, Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial
Open the PDF for Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial in another window
Journal Articles

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

John R. Petrie, Anne L. Peters, Richard M. Bergenstal, Reinhard W. Holl, G. Alexander Fleming, Lutz Heinemann
Journal: Diabetes Care
Diabetes Care 2017;40(12):1614–1621
https://doi.org/10.2337/dci17-0043
Published: 25 October 2017
View article titled, Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: <subtitle>A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group</subtitle>
Open the PDF for Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: <subtitle>A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group</subtitle> in another window
Journal Articles

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

Grazia Aleppo, Katrina J. Ruedy, Tonya D. Riddlesworth, Davida F. Kruger, Anne L. Peters, Irl Hirsch, Richard M. Bergenstal, Elena Toschi, Andrew J. Ahmann, Viral N. Shah, Michael R. Rickels, Bruce W. Bode, Athena Philis-Tsimikas, Rodica Pop-Busui, Henry Rodriguez, Emily Eyth, Anuj Bhargava, Craig Kollman, Roy W. Beck, for the REPLACE-BG Study Group
Journal: Diabetes Care
Diabetes Care 2017;40(4):538–545
https://doi.org/10.2337/dc16-2482
Published: 16 February 2017
View article titled, REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
Open the PDF for REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes

Katharine C. Garvey, Nicole C. Foster, Shivani Agarwal, Linda A. DiMeglio, Barbara J. Anderson, Sarah D. Corathers, Marisa E. Desimone, Ingrid M. Libman, Sarah K. Lyons, Anne L. Peters, Jennifer K. Raymond, Lori M. Laffel
Journal: Diabetes Care
Diabetes Care 2017;40(3):317–324
https://doi.org/10.2337/dc16-1729
Published: 22 December 2016
View article titled, Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes
Open the PDF for Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes

Helena W. Rodbard, Anne L. Peters, April Slee, Anjun Cao, Shana B. Traina, Maria Alba
Journal: Diabetes Care
Diabetes Care 2017;40(2):171–180
https://doi.org/10.2337/dc16-1353
Published: 29 November 2016
View article titled, The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes
Open the PDF for The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Diabetic Ketoacidosis With Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes

Anne L. Peters, Robert R. Henry, Payal Thakkar, Cindy Tong, Maria Alba
Journal: Diabetes Care
Diabetes Care 2016;39(4):532–538
https://doi.org/10.2337/dc15-1995
Published: 15 March 2016
View article titled, Diabetic Ketoacidosis With Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes
Open the PDF for Diabetic Ketoacidosis With Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes in another window
Includes: Supplementary data